Twist Bioscience (TWST)

• Market cap: $1.79B
• 1 day: -3.26%
• 5 days: -9.86%
• 1 month: -4.79%
• 3 months: 18.52%
• 6 months: -9.61%
• Year to date: -34.61%
• 1 year: -34.91%
• 5 years: -69.05%
• 10 years: 111.64%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

Employees: 923